Single Cell Genome Sequencing Market Analysis

By Product

Based on the product segment, the single cell genome sequencing market is divided into reagents and instruments. Out of these, the instruments segment is presently capturing the largest market and is expected to grow with a CAGR of around 15% over the forecast period. This segment is further segmented into next generation sequencing systems, PCR instruments, microarrays and others, out of which, the next generation sequencing instruments segment is expected to occupy the largest market in the year 2020 by generating a revenue of around USD 450 million.

By Application

On the basis of application, the market is segmented into circulating tumor cells, cell differentiation/reprogramming, genomic variation, subpopulation characterization and others. The circulating tumor cells applications segment captured the largest market share 2.22% share in the year 2037 and is expected to grow at a CAGR of 16.37% over the forecast period.

By End-User

The single cell genome sequencing market is segmented on the basis of end-user into hospitals, clinics, research & academic institutions and biotechnology & pharmaceutical companies. The research & academic institutions segment captured the highest market share in 2019 and is expected to reach a market share of around 4.45% in 2037. This is primarily attributed to the rise in investment by government and private entities to improve the research capacities for enhancing genomics studies across the globe as part of academic research.

Our in-depth analysis of the global market includes the following segments: